EUVIMEDEUVIMED entdecken
Crossref

FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity

Yi Ma, Haiping Wu, Shan Chen, Chunmei Xie, Jingjing Hu, Xiemin Qi, Xueping Ma, Yanan Chu, Jingwen Shan, Yan Lu, Lunbiao Cui, Bingjie Zou und 1 weitere

Biosensors and Bioelectronics · 2023

DOI: 10.1016/j.bios.2023.115456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Yi Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China. Hauptthemen laut MEDLINE: Nucleic Acids, COVID-19, Biosensing Techniques, Zika Virus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinase polymerase amplification (RPA) running at 37-42 °C is fast, efficient and less-implemented; however, the existing technologies of nucleic acid testing based on RPA have some limitations in specificity of single-base recognition and multiplexing capability. Herein, we report a highly specific and multiplex RPA-based nucleic acid detection platform by combining flap endonuclease 1 (FEN1)-catalysed invasive reactions with RPA, termed as FEN1-aided RPA (FARPA). The optimal conditions enable RPA and FEN1-based fluorescence detection to occur automatically and sequentially within a 25-min turnaround time and FARPA exhibits sensitivity to 5 target molecules. Due to the ability of invasive reactions in discriminating single-base variation, this one-pot FARPA is much more specific than the Exo probe-based or CRISPR-based RPA methods. Using a universal primer pair derived from tags in reverse transcription primers, multiplex FARPA was successfully demonstrated by the 3-plex assay for the detection of SARS-CoV-2 pathogen (the ORF1ab, the N gene, and the human RNase P gene as the internal control), the 2-plex assay for the discrimination of SARS-CoV-2 wild-type from variants (Alpha, Beta, Epsilon, Delta, or Omicrons), and the 4-plex assay for the screening of arboviruses (zika virus, tick-borne encephalitis virus, yellow fever virus, and chikungunya virus). We have validated multiplex FARPA with 103 nasopharyngeal swabs for SARS-CoV-2 detection. The results showed a 100% agreement with RT-qPCR assays. Moreover, a hand-held FARPA analyser was constructed for the visualized FARPA due to the switch-like endpoint read-out. This FARPA is very suitable for pathogen screening and discrimination of viral variants, greatly facilitating point-of-care diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleic AcidsCOVID-19Biosensing TechniquesZika VirusZika Virus InfectionHumansRecombinasesSensitivity and SpecificityFlap EndonucleasesSARS-CoV-2HydrolasesNucleic Acid Amplification Techniques

Stichwörter der Autor:innen

Invasive reactionsMultiplex detectionNucleic acid detectionRecombinase polymerase amplification (RPA)Single-base recognition

Substanzen

RecombinasesFlap EndonucleasesNucleic AcidsHydrolasesFEN1 protein, human

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China.
  • Department of Clinical Pharmacy, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China; Department of Clinical Pharmacy, Nanjing Jinling Hospital, School of Pharmace…
  • Department of Clinical Pharmacy, Nanjing Jinling Hospital, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China.
  • Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China. Electronic address: zbj523@163.com.
  • Department of Clinical Pharmacy, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China. Electronic address: ghzhou@nju.edu.cn.

Zitieren

APA

Ma, Y., Wu, H., Chen, S., Xie, C., Hu, J., Qi, X., Ma, X., Chu, Y., Shan, J., Lu, Y., Cui, L., Zou, B., & Zhou, G. (2023). FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115456

Vancouver

Ma Y, Wu H, Chen S, Xie C, Hu J, Qi X, et al. FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115456

BibTeX
@article{Ma2023,
  author = {Ma, Yi and Wu, Haiping and Chen, Shan and Xie, Chunmei and Hu, Jingjing and Qi, Xiemin and Ma, Xueping and Chu, Yanan and Shan, Jingwen and Lu, Yan and Cui, Lunbiao and Zou, Bingjie and Zhou, Guohua},
  title = {FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity},
  journal = {Biosensors and Bioelectronics},
  year = {2023},
  doi = {10.1016/j.bios.2023.115456}
}
Kostenlos starten →